Drug programs - modern therapies
Treatment of chronic hepatitis C with interferon-free therapy
---
Free space for your campaign:
OrderWelcome to licensed pharmacies in Poland:
Non-prescription medicines delivery across Europe.
Frequently ordered: potency boosters (sildenafil OTC), quit smoking aids.
Do you have back pain after Epclusa Could it be due to this medicine since it is not mentioned in the leaflet?
Hello with the intake of Epclusa in the afternoon I have back muscle pain at times in the side effects does not bring it while in the sofosbuvir 400 which contains it brings it
EpclusaDrug programs - modern therapiesTreatment of chronic hepatitis C with interferon-free therapy
1 answer
* required field
You can drag the photo file here.
* required field
Notify of a new answer.
Other messages will not be sent.
Other messages will not be sent.
Suggested Products
Space for your product
Katarzyna Chadryś Pharmacist, Editor
18 months ago
Each body reacts differently to the drugs used. Side effects may or may not necessarily occur. They may also be different from those described in the leaflet or the characteristics of the preparation. Both of these preparations are additionally monitored in terms of safety, and data on potential adverse effects are constantly collected. If you experience discomfort with your current treatment, report it to your doctor. He will assess whether they are caused by the drug used or whether they have another cause.
If necessary, you can use the teleconsultation here, it takes place in Polish:
https://www.gdziepolek.pl/telekonsultacja
Adverse reactions should also be reported individually. We wrote about how and why to do it here:
https://www.gdziepolek.pl/artykuly/jak-i-dlaczego-zglaszac-dzialania-niepozadane
Appreciate the answerer and highlight the question on the home page
User questions and answers that provide feedback about products are not verified for the purchase or use of the product. Companies often order anonymous comments to form positive opinions about their products, or negative ones about competitors. Therefore, be guided by the information in the pharmacists' responses in the first place.